- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Submental Fat in New Zealand
Total 3398 results
-
Raziel Therapeutics Ltd.Completed
-
Raziel Therapeutics Ltd.CompletedSubmental FatUnited States
-
Raziel Therapeutics Ltd.CompletedSubmental FatUnited States
-
Neothetics, IncCompletedSubmental FatUnited States
-
Kythera BiopharmaceuticalsCompletedHealthy | Submental FatUnited States, Canada, Australia, United Kingdom
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedSubmental FullnessUnited States, Canada
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
FibroGenTerminatedFocal Segmental GlomerulosclerosisUnited States
-
Liggins InstituteRecruiting
-
Tavotek BiotherapeuticsRecruiting
-
Genzyme, a Sanofi CompanyCompletedFocal Segmental GlomerulosclerosisUnited States, Germany, United Kingdom, Italy
-
ReCode TherapeuticsRecruitingCystic FibrosisNew Zealand
-
Arcturus Therapeutics, Inc.Novotech CRORecruiting
-
Arrowhead PharmaceuticalsRecruitingFacio-Scapulo-Humeral DystrophyNew Zealand
-
Arthrosi TherapeuticsCompletedGout PatientsNew Zealand
-
Yale UniversityUnited States Department of DefenseRecruitingFocal Segmental GlomerulosclerosisUnited States
-
Arcturus Therapeutics, Inc.CompletedOrnithine Transcarbamylase DeficiencyNew Zealand
-
ProtalixRecruiting
-
Astellas Pharma Global Development, Inc.Kyowa Kirin Co., Ltd.CompletedKidney Transplantation | Primary Focal Segmental Glomerulosclerosis (FSGS)United States, Canada
-
DePuy InternationalCompletedOsteoarthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Traumatic Femoral Fractures | Nonunion of Femoral FracturesNew Zealand
-
ChemoCentryxMedpace, Inc.CompletedFocal Segmental Glomerulosclerosis | FSGS | GlomerulosclerosisUnited States, France, Italy, Australia, United Kingdom, Canada, New Zealand, Poland
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedFocal Segmental GlomerulosclerosisUnited States, Canada
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
Arrowhead PharmaceuticalsCompleted
-
Dimerix Bioscience Pty LtdIqvia Pty LtdCompletedFocal Segmental GlomerulosclerosisAustralia
-
Genzyme, a Sanofi CompanyCompletedPrimary Focal Segmental GlomerulosclerosisUnited States, Brazil, Germany, Italy, Spain
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
SurModics, Inc.Active, not recruitingHemodialysis Access FailureAustralia, New Zealand
-
Complexa, Inc.Medpace, Inc.; MicroConstants; Kidney Research Network, formerly NephCure Accelerating... and other collaboratorsCompletedPrimary Focal Segmental GlomerulosclerosisUnited States
-
Mallinckrodt ARD LLCCompletedIdiopathic Focal Segmental GlomerulosclerosisUnited States, Argentina, Turkey, Peru, Australia, Chile, Mexico
-
Kaneka Medical America LLCRecruitingFocal Segmental GlomerulosclerosisUnited States
-
Aurinia Pharmaceuticals Inc.TerminatedFocal Segmental GlomerulosclerosisUnited States, Dominican Republic
-
Arrowhead PharmaceuticalsRecruitingMyotonic Dystrophy 1New Zealand, Australia
-
Cystetic Medicines, Inc.DevPro BiopharmaRecruitingCystic FibrosisAustralia, New Zealand
-
Tenet MedicinesTerminatedFocal Segmental Glomerulosclerosis | Minimal Change DiseaseUnited States
-
Kaneka Medical America LLCRecruitingFocal Segmental GlomerulosclerosisUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Monash Medical CentreMonash University; University of Auckland, New Zealand; Hudson Institute of Medical... and other collaboratorsRecruiting
-
Northwell HealthTerminatedCardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental GlomerulosclerosisChronic Kidney Disease | Focal Segmental Glomerulosclerosis | Nephrotic Syndrome | Steroid Resistant Nephrotic SyndromeUnited States
-
Northwell HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingFocal Segmental Glomerulosclerosis | Minimal Change Disease | Nephrotic Syndrome in ChildrenUnited States
-
Northwell HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingFocal Segmental Glomerulosclerosis | Minimal Change Disease | Nephrotic Syndrome in ChildrenUnited States
-
PfizerTerminatedFocal Segmental Glomerulosclerosis (FSGS)United States, Spain, Czechia, Canada, France, Germany, United Kingdom, Poland, Japan, Mexico, Italy, Slovakia
-
Northwell HealthThe Cleveland Clinic; University of North CarolinaCompletedFocal GlomerulosclerosisUnited States
-
GlaxoSmithKlineCompletedGlomerulosclerosis, Focal SegmentalUnited States, Canada
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Verve Therapeutics, Inc.Active, not recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom